News Releases

Search by year or by keyword :

Date	Title
2020-12-30	Amarillo Biosciences, Inc. Enters into a Securities Purchase Agreement to Foster New Growth.
2020-09-10	Amarillo Biosciences to Initiate Low-Dose Interferon Clinical Trials to Treat COVID-19, Appoints Interferon Specialist Dr. Manfred Beilharz to Scientific Advisory Board.
2020-08-13	Amarillo Biosciences to Reaffirm Low-Dose Interferon Research Leadership Position and Global Commitment to Support Related Therapeutics.
2020-02-13	Amarillo Biosciences to Explore Low-Dose Oral Interferon Therapeutics in China as a Line of Defense Against Coronavirus and Other Viral Indications.
2019-07-29	Amarillo Biosciences and Xiamen Weiyang Pharmaceutical Sign Term Sheet Outlining China Licensing and Royalty Agreement
2018-08-23	Amarillo Biosciences First-Half 2018 Business Update.
2017-09-06	Amarillo Biosciences, Inc. Announces Investor Update (Sept 6, 2017)
2015-05-18	Amarillo Biosciences, Inc. Summarizes New Plan of Operation.
2015-02-02	Amarillo Biosciences, Inc. Reorganizes, Exits Bankruptcy, and Opens a New Chapter in the Healthcare Industry.

United States:

Taiwan: